Cannabis Law Report

APRIL 8, 2022

To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 9, 2021

The bill was approved by the State Senate on June 1, 2021, and was approved by the Assembly’s Public Safety Committee on June 29, 2021. Although ketamine is an FDA approved anesthetic with a long history of use in the clinical setting, it appears that ketamine may have uses beyond anesthetizing patients. Ashcroft , 282 F.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 21, 2019

The detailed history of California’s conformity to Federal law continues with: 2012 Conformity. This act runs from 2008 through 2012 and reauthorizes most programs of the 2002 farm bill. BCC has provided guidance with respect to the retention of required accounting records in Sec. 6081) enacted June 17, 2008.

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40